Key Man Clause in Private Fund LPAs: What Actually Happens When It Triggers
TL;DR: A key man clause (also called a "key person" provision) is the section of a fund's limited partnership agreement, or LPA (the contract governing how a private fund operates and how the general...

I've read more LPAs than I care to admit, and the key man clause is one of those provisions everyone nods along to during due diligence and almost nobody actually reads closely. That's a mistake. It's the single mechanism that determines what happens to your capital if the person you actually backed (not the fund's brand, not the pitch deck, the actual person) gets hit by a car, has a falling out with their partners, or decides to retire early. You're not investing in a logo. You're investing in two or three people's judgment, and the key man clause is the only contractual language that acknowledges that fact.
What a key man clause actually is
Strip away the legal drafting and a key man clause does one thing. It names specific individuals, the "key persons," whose continued, active involvement is a condition of the fund operating normally. If one or more of those named people stop devoting the time and attention the LPA requires, a "key person event" is triggered, and the fund's ability to make new investments is automatically restricted, usually paused entirely, until the limited partners decide what happens next.
Why does this exist? Because when you commit capital to a private fund, you're underwriting a small number of people, not an institution. Goodwin Procter's 2024 review of fund terms found that 88% of private equity, real estate, venture, debt, and infrastructure funds automatically suspend the investment period (the window during which the fund is allowed to call capital and make new investments) the moment a key person event occurs. That's close to universal. Limited partners, as a class, have decided this protection is non-negotiable, and general partners have largely stopped fighting it.
The logic is straightforward. A fund's edge, whatever it is, usually lives in the heads of a handful of senior people: sourcing relationships, an operational playbook, a particular sector network built over decades. If those people leave or become unable to work, the fund's ability to generate the returns you underwrote goes with them. The key man clause gives you a mechanism to stop new capital from flowing into an entity that no longer resembles the one you diligenced, while everyone figures out what comes next.
What happens mechanically when it triggers
This is where most investors' understanding gets fuzzy, so let me walk through the actual sequence.
Step one: the investment period suspends automatically. The moment a named key person event occurs (resignation, death, disability, termination for cause, or in some LPAs a "change of control" of the management company), the fund's right to call capital for new investments halts. No vote is required to trigger this. It's automatic by contract design, which is the point. You don't want the general partner (GP), the entity that manages the fund's investments day to day, deciding on its own whether the departure of its own founder is a big deal.
Step two: the GP gets a resolution window. The general partner typically has a defined period, roughly 90 to 180 days per lecocqassociate's 2025 review of fund terms, to propose a fix. That might mean naming a replacement key person, restructuring the investment committee, or presenting a continuity plan to the limited partner advisory committee, or LPAC. The LPAC is a subset of LPs (typically the largest or earliest commitments) empowered to act on behalf of the full LP base on certain governance matters without calling a vote of every investor.
Step three: a vote decides reinstatement. Whether the LPAC alone can reinstate the investment period, or whether it requires a vote of all limited partners, is one of the most consequential drafting differences between funds. Goodwin's terms database found that 66% of funds require a full LP vote to reinstate; only 34% delegate that decision to the LPAC alone. If you're a smaller LP and your fund delegates to LPAC-only reinstatement, understand that you may have zero direct say in whether the fund resumes investing after a key person event. The largest checks decide for you.
Step four: there's a hard deadline, and it usually kills the fund's investing activity if missed. Per Goodwin's data, 92% of funds automatically and permanently terminate the investment period if the key person event isn't resolved by the deadline. Note the distinction: this typically ends new investing, not the fund itself. Existing portfolio companies still get managed, existing positions still get held or exited, but the fund stops deploying fresh capital into new deals. ILPA's own Model LPA language builds this in explicitly, providing for "the reduction of carried interest to the GP by 100% upon a vote of the LP to Remove a GP for cause," alongside automatic investment-period termination if remediation isn't approved in time.
How long does the freeze actually last? Per Goodwin's April 2024 terms review, 60% of funds cap the suspension period at three to nine months, while roughly 25% allow it to run nine months or longer. Debt funds are the most likely structure to permit suspensions stretching past twelve months. ILPA's own Principles 3.0 recommend the suspension become permanent within 90 to 180 days absent a supermajority vote to reinstate. That's a wide enough range that "there's a key man clause" tells you almost nothing useful on its own. The number of months matters enormously to how exposed your committed but uncalled capital is during that window.
GP removal. A key person event is also frequently one of several triggers tied to LP rights to remove the general partner, sometimes "for cause" (fraud, gross negligence, material breach) with full forfeiture of carried interest, sometimes "no-fault" with a partial haircut instead. These are usually separate provisions cross-referenced with the key person section, and the vote thresholds to exercise them are typically higher (a supermajority) than the thresholds needed to simply pause the investment period.
A practical checklist: what to ask before you commit capital
Ask these questions before you sign, not after. Most of this information is in the LPA itself, but a direct conversation with the GP or their counsel, or a question routed through the placement agent, will get you a clearer answer faster than parsing dense contract language on your own.
- Who exactly is named as a "key person"? Get the actual names, not job titles. ILPA's guidance is explicit that key persons "should be the individuals that will determine investment outcomes of the fund, not solely the founders, regardless of the title they have." A fund can have a famous founder who isn't actually the person underwriting deals day to day.
- How many named individuals must depart to trigger the clause? Some LPAs require all named key persons to leave; others trigger on any single departure. A three-person key person list requiring unanimous departure is functionally weaker protection than a two-person list that triggers on either one leaving.
- What exactly counts as "ceasing to devote time and attention"? This is the phrase that generates litigation. Vague language here is a real risk. Ambiguity over what "ceased active involvement" means was central to the 2026 First Department appellate ruling in AlphaSense, Inc. v. Financial Tech. Partners LP, where contract ambiguity defeated an early motion to dismiss and pushed the dispute deeper into litigation. Ask for the precise definition, including carve-outs for sabbaticals, board seats at other companies, or part-time consulting arrangements.
- What is the length of the cure period, and who decides reinstatement? Get the specific number of months, and find out whether reinstatement requires a full LP vote or only an LPAC vote. If you're not on the LPAC and the fund delegates reinstatement decisions to it, you have no direct vote on this outcome.
- What happens to capital calls during a suspension? Confirm whether the GP can still call capital for follow-on investments in existing portfolio companies, for fund expenses, or for management fees during a freeze. This differs meaningfully across LPAs and determines how "frozen" your commitment really is.
- Is there an interim clawback or valuation test tied to the event? ILPA recommends performing a clawback test (checking whether the GP has been overpaid in carried interest relative to actual fund performance) at the moment of a key person event, to catch any deficiency before more capital moves.
- What is the deadline for permanent termination of the investment period if the issue isn't resolved? Know the outer boundary. Most funds land in the 90-to-180-day range for this backstop, but a meaningful minority run longer.
An honest caveat: this rarely plays out in public, and that's the point
I looked for a real, documented example of a key man clause triggering, where a fund actually froze, voted, and resolved it. The kind of concrete case study that makes for a satisfying story. I couldn't verify one. What surfaced instead was litigation over whether a key person event had occurred at all. The AlphaSense v. Financial Tech. Partners dispute is a fight about contract ambiguity, not a documented walkthrough of a clean trigger-and-cure cycle. I want to be straightforward about that rather than stretch a legal dispute into something it isn't.
That absence is itself informative. Key person events are, by design, resolved privately between the GP and its LPAC or LP base long before they become public. Limited partners with real negotiating leverage, pension funds, endowments, large family offices, push hard on this exact provision during fundraising precisely because they know a bad draft is expensive to fix after the fact. The result is that well-negotiated funds rarely reach a public dispute over this clause. The mechanism does its job quietly, out of view. The funds you're more likely to hear about are the ones with ambiguous language, like the drafting dispute in the AlphaSense case, where the definition of "ceased active involvement" wasn't tight enough to avoid a fight.
The practical lesson isn't that key man clauses don't matter because nothing dramatic happens. It's closer to the opposite. They matter enough that sophisticated LPs negotiate the ambiguity out before signing, and you should treat your own review with the same seriousness, even on a smaller check size where you have less individual leverage to demand changes.
The takeaway
Before you commit capital to any closed-end private fund, get the key person names, the trigger definition, the cure period length in months, and the reinstatement vote threshold in writing, and read them yourself rather than taking a summary from the placement memo. If the GP or their counsel can't give you crisp, specific answers to the checklist above, that's information too. A fund with tight, well-drafted key person language is telling you its counsel and its LPs have already done the hard negotiating work. A fund that waves the question away is asking you to underwrite people risk with no contractual backstop if that risk materializes.
Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.
Topics
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBA
Continue Reading

Blackstone's $676 Million FUTRONIC Deal: What PE's Robotics Bet Signals for Accredited Investors

Uplift Investors Closes Debut Fund at $670M Hard Cap: What the Ex-H.I.G. Trio's Raise Says About LP Risk Appetite

Citation Capital's $1.2 Billion Debut Fund Defies the Worst PE Fundraising Drought in Years

Recallable Capital and Recycling Provisions: What They Really Cost LPs

Feeder Funds Explained: How Private Equity's Access Vehicles Work (and Where the Fees Hide)
